Enhanced T cell proliferative response to type II collagen and synthetic peptide CII (255-274) in patients with rheumatoid arthritis

Arthritis and Rheumatism

Volumn 42, Issue 10, 1999, Pages 2085-2093

  Kim, Ho Youn ^a   Kim, Wan Uk ^a   Cho, Mi La ^a   Lee, Suk Kyeong ^a   Youn, Jeehee ^a   Kim, Sung Il ^b   Yoo, Wan Hee ^c   Park, Jae Ho ^d   Min, Jun Ki ^a   Lee, Sang Heon ^a   Park, Sung Hwan ^a   Cho, Chul Soo ^a  

^a The Catholic University of Korea   (South Korea)

^b Pusan National University   (South Korea)

^c Chonbuk National University   (South Korea)

^d Keimyung University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 2; EPITOPE; SYNTHETIC PEPTIDE;

ADULT; AGED; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; MIXED LYMPHOCYTE CULTURE; MONONUCLEAR CELL; OSTEOARTHRITIS; PATHOGENESIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; T LYMPHOCYTE ACTIVATION;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ARTHRITIS, RHEUMATOID; CATTLE; CELL DIVISION; CELLS, CULTURED; COLLAGEN; FEMALE; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; SYNOVIAL FLUID; T-LYMPHOCYTES;

EID: 0033508320     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199910)42:10<2085::AID-ANR8>3.0.CO;2-Z     Document Type: Article

References (41)

1. Trentham DE, Townes AS, Kang AH. Autoimmunity to type II collagen: an experimental model of arthritis. J Exp Med 1977;146: 857-68.
2. Courtenay JS, Dallman MJ, Dayan AD, Martin A, Mosedale B. Immunisation against heterologous type II collagen induces arthritis in mice. Nature 1980;283:666-8.
3. Holmdahl R, Klareskog L, Rubin K, Larsson E, Wigzell H. T lymphocytes in collagen II-induced arthritis in mice: characterization of arthritogenic collagen II-specific T-cell lines and clones. Scand J Immunol 1985;22:295-306.
4. Seki N, Sudo Y, Yoshioka T, Sugihara S, Fujitsu T, Sakuma S, et al. Type II collagen-induced murine arthritis. I. Induction and perpetuation of arthritis require synergy between humoral and cell-mediated immunity. J Immunol 1988;140:1477-84.
5. Trentham DE, Dynesius RA, Rocklin RE, David JR. Cellular sensitivity to collagen in rheumatoid arthritis. N Engl J Med 1978;299:327-32.
6. Stuart JM, Postlethwaite AE, Townes AS, Kang AH. Cell mediated immunity to collagen and collagen alpha chains in rheumatoid arthritis and other rheumatic disease. Am J Med 1980;69:13-8.
7. Londei M, Savil CM, Verhoef A, Brennan F, Leech ZA, Duance V, et al. Persistence of collagen type II specific T-cell clones in synovial membrane of a patient with rheumatoid arthritis. Proc Natl Acad Sci U S A 1989;86:636-40.
8. Desai BV, Dixit S, Pope RM. Limited proliferative response to type II collagen in rheumatoid arthritis. J Rheumatol 1989;16:1310-4.
9. Snowden N, Reynolds I, Morgan K, Holt L. T cell responses to human type II collagen in patients with rheumatoid arthritis and healthy controls. Arthritis Rheum 1997;40:1210-8.
10. Krco CJ, Pawelski J, Harders J, McCormick D, Griffiths M, Luthra HS, et al. Characterization of the antigenic structure of human type II collagen. J Immunol 1996;156:2761-8.
11. Rosloniec EF, Brand DD, Myers LK, Esaki Y, Whittington KB, Zaller DM, et al. Induction of autoimmune arthritis in HLA-DR4 (DRB1*0401) transgenic mice by immunization with human and bovine type II collagen. J Immunol 1998;160:2573-8.
12. Brand DD, Myers LK, Terato K, Whittington KB, Stuart JM, Kang AH, et al. Characterization of the T cell determinants in the induction of autoimmune arthritis by bovine alpha 1(II)-CB11 in H-2q mice. J Immunol 1994;152:3088-97.
13. Myers LK, Miyahara H, Terato K, Seyer JM, Stuart JM, Kang AH. Collagen-induced arthritis in B10.RIII mice (H-2r): identification of an arthritogenic T-cell determinant. Immunology 1995;84:509-13.
14. Parish CR. The relationship between humoral and cell mediated immunity. Transplant Rev 1972;13:35-66.
15. Katsura Y. Cell mediated and humoral immune responses in mice. III. Dynamic balance between delayed type hypersensitivity and antibody response. Immunology 1977;32:227-35.
16. Heinzel FP, Sadick MD, Holaday BJ, Coffman RL, Locksley RM. Reciprocal expression of interferon gamma or IL-4 during the resolution or progression of murine leishmaniasis: evidence for expansion of distinct helper T cell subsets. J Exp Med 1989;169: 59-72.
17. Terato K, DeArmey DA, Ye XY, Griffiths MM, Cremer MA. The mechanism of autoantihody formation to cartilage in rheumatoid arthritis: possible cross-reaction of antibodies to dietary collagens with autologous type II collagen. Clin Immunol Immunopathol 1997;79:142-54.
18. Cook AD, Rowley MJ, Mackay IR, Gough A, Emery P. Antibodies to type II collagen in early rheumatoid arthritis: correlation with disease progression. Arthritis Rheum 1996;39:1720-7.
19. Stuart JM, Cremer MA, Townes AS, Kang AH. Type II collagen induced arthritis in rats: passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis. J Exp Med 1982;155:1-16.
20. Terato K, Hasty KA, Reife RA, Cremer MA, Kang AH, Stuart JM. Induction of arthritis with monoclonal antibodies to collagen. J Immunol 1992;148:2103-8.
21. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
22. Wahl SM, Malone DG, Wilder RL. Spontaneous production of fibroblast-activating factor(s) by synovial inflammatory cells: a potential mechanism for enhanced tissue destruction. J Exp Med 1985;161:210-22.
23. Fujii K, Tsuji M, Murota K, Terato K, Shimozuru Y, Nagai Y. An improved enzyme-linked immunosorbent assay of anti-collagen antibodies in human serum. J Immunol Methods 1989;124:63-70.
24. Tsuji K, Aizawa M, Sasazuki T, editors. HLA 1991: proceedings of the eleventh International Histocompatibility Workshop and Conference. Oxford: Oxford University Press; 1992. p. 83-108.
25. Firestein GS, Zvaifler NJ. How important are T cells in chronic rheumatoid synovitis? Arthritis Rheum 1990;33:768-73.
26. Weiner HL, Mackin GA, Matsui M, Orav EJ, Khoury SJ, Dawson DM, et al. Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 1993;259:1321-4.
27. Trentham DE, Dynesius-Trentham RA, Orav EJ, Combitchi D, Lorenzo C, Sewell KL, et al. Effects of oral administration of type II collagen on rheumatoid arthritis. Science 1993;261: 1727-30.
28. Zhang ZJ, Davidson L, Eisenbarth G, Weiner HL. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc Natl Acad Sci U S A 1991;88:10252-6.
29. Nussenblatt RB, Caspi RR, Mahdi R, Chan CC, Roberge F, Lider O, et al. Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. J Immunol 1990;144:1689-95.
30. Barnett ML, Kremer JM, St. Clair EW, Clegg DO, Furst D, Weisman M, et al. Treatment of rheumatoid arthritis with oral type II collagen: results of a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum 1998;41:290-7.
31. Khare SD, Kreo CJ, Griffiths MM, Luthra HS, David CS. Oral administration of an immunodominant human collagen peptide modulate collagen induced arthritis. J Immunol 1995;155:3653-9.
32. De Aizpurua HJ, Wilson YM, Harrison LC. Glutamic acid decarboxylase autoantibodies in preclinical insulin-dependent diabetes. Proc Natl Acad Sci U S A 1992;89:9841-5.
33. Harrison LC, Honeyman MC, DeAizpurua HJ, Schmidli RS, Colman PG, Tait BD, et al. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet 1993;341:1365-9.
34. Saoudi A, Simmonds S, Huitinga I, Mason D. Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells: evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of the autoantigen-specific T cells. J Exp Med 1995; 182:335-44.
35. Greenbury CL, Skingle J. Anti-collagen antibody. J Clin Pathol 1979;32:826-31.
36. Cook AD, Rowley MJ, Stockman A, Muirden KD, Mackay IR. Specificity of antibodies to type II collagen in early rheumatoid arthritis. J Rheumatol 1994;21:1186-91.
37. Kim W-U, Lee S-S, Joo Y-S, Min J-K, Hong Y-S, Lee S-H, et al. IgG antibodies to native bovine type II collagen reflect disease activity in rheumatoid arthritis [abstract]. Arthritis Rheum 1998;41 Suppl 9:S313.
38. Morgan K, Clague RB, Collins I, Ayad S, Phinn SD, Holt PJL. A longitudinal study of anticollagen antibodies in patients with rheumatoid arthritis. Arthritis Rheum 1989;32:139-45.
39. Gregersen PK, Shen M, Song QL, Merryman P, Degar S, Seki T, et al. Molecular diversity of HLA-DR4 haplotypes. Proc Natl Acad Sci U S A 1986;83:2642-6.
40. Wordsworth BP, Lanchbury JS, Sakkas LI, Welsh KI, Panayi GS, Bell JI. HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region. Proc Natl Acad Sci U S A 1989;86:10049-53.
41. Solinger AM, Stobo JD. Immune response gene control of collagen reactivity in man: collagen unresponsiveness in HLA-DR4 negative nonresponders is due to the presence of T-dependent suppressive influences. J Immunol 1982;129:1916-20.